Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib.

Manwani R, Cohen O, Sharpley F, Mahmood S, Sachchithanantham S, Foard D, Lachmann HJ, Quarta C, Fontana M, Gillmore JD, Whelan C, Hawkins PN, Wechalekar AD.

Blood. 2019 Dec 19;134(25):2271-2280. doi: 10.1182/blood.2019000834.

PMID:
31578202
2.

Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers.

Rezk T, Lachmann HJ, Fontana M, Naharro AM, Sachchithanantham S, Mahmood S, Petrie A, Whelan CJ, Pinney JH, Foard D, Lane T, Youngstein T, Wechalekar AD, Hawkins PN, Gillmore JD.

Br J Haematol. 2019 Aug;186(3):460-470. doi: 10.1111/bjh.15955. Epub 2019 May 24.

PMID:
31124579
3.

Bioimpedance vector analysis for the detection of extracellular volume overload and sarcopenia in systemic AL amyloidosis.

Rezk T, Davenport A, Gan JJ, Lachmann HJ, Fontana M, Martinez-Naharro A, Sachchithanantham S, Guillotte C, Mahmood S, Petrie A, Whelan CJ, Pinney JH, Foard D, Lane T, Youngstein T, Wechalekar AD, Hawkins PN, Gillmore JD.

Br J Haematol. 2019 Jun;185(5):977-980. doi: 10.1111/bjh.15675. Epub 2018 Nov 18. No abstract available.

PMID:
30450572
4.

Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine.

Manwani R, Sachchithanantham S, Mahmood S, Foard D, Sharpley F, Rezk T, Lane T, Quarta C, Fontana M, Lachmann HJ, Gillmore JD, Whelan C, Hawkins PN, Wechalekar AD.

Blood. 2018 Aug 16;132(7):761-764. doi: 10.1182/blood-2018-04-846493. Epub 2018 Jun 20. No abstract available.

PMID:
29925500
5.

Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis.

Manwani R, Foard D, Mahmood S, Sachchithanantham S, Lane T, Quarta C, Youngstein T, Rezk T, Lachmann HJ, Gillmore JD, Fontana M, Whelan C, Hawkins PN, Wechalekar A.

Haematologica. 2018 Apr;103(4):e165-e168. doi: 10.3324/haematol.2017.178095. Epub 2018 Jan 5. No abstract available.

6.

Prolonged renal survival in light chain amyloidosis: speed and magnitude of light chain reduction is the crucial factor.

Rezk T, Lachmann HJ, Fontana M, Sachchithanantham S, Mahmood S, Petrie A, Whelan CJ, Pinney JH, Foard D, Lane T, Youngstein T, Wechalekar AD, Bass P, Hawkins PN, Gillmore JD.

Kidney Int. 2017 Dec;92(6):1476-1483. doi: 10.1016/j.kint.2017.05.004. Epub 2017 Jul 18.

PMID:
28729034
7.

Six-minute walk test (6MWT) in AL amyloidosis - baseline and 12-month follow-up after chemotherapy.

Flatman K, Foard D, Pyart E, Hughes G, Gaudia R, Kearney C, Elmi I, Bangova A, Libo-On P, Caringal-Galima J, Rowles E, Guillotte C, Hawkins P, Gillmore J, Lane T.

Amyloid. 2017 Mar;24(sup1):62-63. doi: 10.1080/13506129.2017.1293516. No abstract available.

PMID:
28434348
8.

A good clonal response to chemotherapy in AL amyloidosis is associated with improved quality of life and function at 1 year.

Carter JP, Foard D, Rannigan L, Aliaz K, Mahmood S, Sachchithanantham S, Fontana M, Quarta C, Martinez De Azcona Naharro A, Youngstein T, Rezk T, Wechalekar A, Whelan C, Lachmann H, Hawkins P, Gillmore J, Lane T.

Amyloid. 2017 Mar;24(sup1):72-73. doi: 10.1080/13506129.2017.1295944. No abstract available.

PMID:
28434320
9.

Comparison of Free Light Chain Assays:  Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain Amyloidosis.

Mahmood S, Wassef NL, Salter SJ, Sachchithanantham S, Lane T, Foard D, Whelan CJ, Lachmann HJ, Gillmore JD, Hawkins PN, Wechalekar AD.

Am J Clin Pathol. 2016 Jul;146(1):78-85. doi: 10.1093/ajcp/aqw079. Epub 2016 Jun 27.

PMID:
27353767
10.

Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis.

Sachchithanantham S, Offer M, Venner C, Mahmood SA, Foard D, Rannigan L, Lane T, Gillmore JD, Lachmann HJ, Hawkins PN, Wechalekar AD.

Haematologica. 2015 Nov;100(11):1469-76. doi: 10.3324/haematol.2015.128025. Epub 2015 Aug 20.

11.

Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting.

Venner CP, Gillmore JD, Sachchithanantham S, Mahmood S, Lane T, Foard D, Roussel M, Rannigan L, Gibbs SDj, Pinney JH, Whelan CJ, Lachmann HJ, Hawkins PN, Wechalekar AD.

Haematologica. 2014 Dec;99(12):e260-3. doi: 10.3324/haematol.2014.108191. Epub 2014 Sep 5. No abstract available.

12.

A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis.

Venner CP, Gillmore JD, Sachchithanantham S, Mahmood S, Lane T, Foard D, Rannigan L, Gibbs SD, Pinney JH, Whelan CJ, Lachmann HJ, Hawkins PN, Wechalekar AD.

Leukemia. 2014 Dec;28(12):2304-10. doi: 10.1038/leu.2014.218. Epub 2014 Jul 16.

PMID:
25027514
13.

Lenalidomide and dexamethasone for systemic AL amyloidosis following prior treatment with thalidomide or bortezomib regimens.

Mahmood S, Venner CP, Sachchithanantham S, Lane T, Rannigan L, Foard D, Pinney JH, Gibbs SD, Whelan CJ, Lachmann HJ, Gillmore JD, Hawkins PN, Wechalekar AD.

Br J Haematol. 2014 Sep;166(6):842-8. doi: 10.1111/bjh.12973. Epub 2014 Jun 13.

PMID:
24930361
14.

A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis.

Wechalekar AD, Schonland SO, Kastritis E, Gillmore JD, Dimopoulos MA, Lane T, Foli A, Foard D, Milani P, Rannigan L, Hegenbart U, Hawkins PN, Merlini G, Palladini G.

Blood. 2013 Apr 25;121(17):3420-7. doi: 10.1182/blood-2012-12-473066. Epub 2013 Mar 11.

PMID:
23479568
15.

Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival.

Venner CP, Lane T, Foard D, Rannigan L, Gibbs SD, Pinney JH, Whelan CJ, Lachmann HJ, Gillmore JD, Hawkins PN, Wechalekar AD.

Blood. 2012 May 10;119(19):4387-90. doi: 10.1182/blood-2011-10-388462. Epub 2012 Feb 13.

PMID:
22331187
16.

High-resolution microscopic methods for the analysis of cellular movements in Drosophila embryos.

Kiehart DP, Montague RA, Rickoll WL, Foard D, Thomas GH.

Methods Cell Biol. 1994;44:507-32. Review. No abstract available.

PMID:
7707969
17.

Isolation and sequence of cDNA encoding the soybean protease inhibitors PI IV and C-II.

Joudrier PE, Foard DE, Floener LA, Larkins BA.

Plant Mol Biol. 1987 Jan;10(1):35-42. doi: 10.1007/BF00014184.

PMID:
24277461
18.

Molecular cloning and analysis of a gene coding for the Bowman-Birk protease inhibitor in soybean.

Hammond RW, Foard DE, Larkins BA.

J Biol Chem. 1984 Aug 10;259(15):9883-90.

19.

In vitro synthesis of the Bowman-Birk and related soybean protease inhibitors.

Foard DE, Gutay PA, Ladin B, Beachy RN, Larkins BA.

Plant Mol Biol. 1982 Sep;1(3):227-43. doi: 10.1007/BF00021034.

PMID:
24317965
20.
21.
22.

Lectin release by soybean seeds.

Fountain DW, Foard DE, Replogle WD, Yang WK.

Science. 1977 Sep 16;197(4309):1185-7.

PMID:
17753336
23.

A soybean trypsin inhibitor. Crystallization and x-ray crystallographic study.

Hwang DL, Foard DE, Wei CH.

J Biol Chem. 1977 Feb 10;252(3):1099-101.

24.

A genetic approach to the increase of methionine content in legume seeds.

Foard DE.

Basic Life Sci. 1976 Mar 1-7;8:413-4. No abstract available.

PMID:
1032112
25.

Electrophoretic methods for detecting differences in seed proteins of soybean varieties and induced mutants.

Lowry KL, Caton JE, Foard DE.

J Agric Food Chem. 1974 Nov-Dec;22(6):1043-5. No abstract available.

PMID:
4473474
26.

Physiologically normal senescence in seedlings grown without cell division after massive gamma-irradiation of seeds.

Foard DE, Haber AH.

Radiat Res. 1970 May;42(2):372-80. No abstract available.

PMID:
5442405
27.

Actions of gibberellic and abscisic acids on lettuce seed germination without actions on nuclear DNA synthesis.

Haber AH, Foard DE, Perdue SW.

Plant Physiol. 1969 Mar;44(3):463-7. No abstract available.

28.

Mitoses in thermodormant lettuce seeds with reference to histological location, localized expansion, and seed storage.

Foard DE, Haber AH.

Planta. 1966 Jun;71(2):160-70. doi: 10.1007/BF00390135.

PMID:
24554013

Supplemental Content

Support Center